INSIGNIA

Serial Number 90149626
Registration 7357841
700

Registration Progress

Application Filed
Aug 31, 2020
Under Examination
Approved for Publication
Jan 2, 2024
Published for Opposition
Jan 2, 2024
Registered
Apr 16, 2024

Trademark Image

INSIGNIA

Basic Information

Serial Number
90149626
Registration Number
7357841
Filing Date
August 31, 2020
Registration Date
April 16, 2024
Published for Opposition
January 2, 2024
Drawing Code
5

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 16, 2024
Registration
Registered
Classes
001 005 010 042

Rights Holder

SpeeDx Pty Ltd

99
Address
Suite G16, National Innovation Centre,
Australian Techn. Pk, 4 Cornwallis St.
Eveleigh NSW2015
AU

Ownership History

SpeeDx Pty Ltd

Original Applicant
99
Eveleigh AU

SpeeDx Pty Ltd

Owner at Publication
99
Eveleigh AU

SpeeDx Pty Ltd

Original Registrant
99
Eveleigh AU

Legal Representation

Attorney
Joi A. White

USPTO Deadlines

Next Deadline
1715 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-16)
Due Date
April 16, 2030
Grace Period Ends
October 16, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

50 events
Date Code Type Description Documents
Apr 16, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Apr 16, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 11, 2024 ETOP T EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED Loading...
Feb 22, 2024 CHPB I POST PUBLICATION AMENDMENT - ENTERED Loading...
Feb 20, 2024 APET A ASSIGNED TO PETITION STAFF Loading...
Jan 23, 2024 ETOF T EXTENSION OF TIME TO OPPOSE RECEIVED Loading...
Jan 19, 2024 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Jan 2, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 2, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 13, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 19, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Sep 19, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Sep 19, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Sep 19, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 19, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Sep 12, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN Loading...
Sep 5, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY Loading...
Aug 21, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 21, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 21, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED Loading...
Aug 21, 2023 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Aug 19, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 18, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 18, 2023 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 31, 2023 GNFR O FINAL REFUSAL E-MAILED Loading...
May 31, 2023 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 31, 2023 CNFR R FINAL REFUSAL WRITTEN Loading...
May 13, 2023 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 12, 2023 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 12, 2023 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Feb 14, 2023 GNRT O NON-FINAL ACTION E-MAILED Loading...
Feb 14, 2023 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 14, 2023 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 8, 2022 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Aug 8, 2022 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 8, 2022 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jul 27, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jul 22, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION Loading...
Jan 20, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED Loading...
Jul 22, 2021 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Jul 22, 2021 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Jul 22, 2021 CNSL R SUSPENSION LETTER WRITTEN Loading...
Jul 21, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 21, 2021 ALIE A ASSIGNED TO LIE Loading...
Jul 21, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 6, 2021 PARI I TEAS VOLUNTARY AMENDMENT RECEIVED Loading...
Jul 5, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 5, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 5, 2021 GNRT F NON-FINAL ACTION E-MAILED Loading...

Detailed Classifications

Class 001
Chemicals used in industry, science, photography, agriculture, horticulture and forestry, except fungicides, herbicides, insecticides, and parasiticides; reagents and reactants for non-medical purposes; enzymes for industrial or scientific purposes; nucleic acid for other than medical and veterinary purposes; nucleic recombinant acids for other than medical and veterinary purposes; acids, namely, inorganic acids for industrial purposes; DNA and RNA polymerase; chemicals used in food processing and screening; chemicals used in environmental monitoring
Class 005
Pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune-suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; enzymes for pharmaceutical, veterinary and medical purposes; medical kits containing medical and/or pharmaceutical preparations and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of reagents and assays for medical laboratory use in analysis that test for the presence of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders
Class 010
Surgical apparatus and instruments; medical and veterinary apparatus and instruments for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing apparatus and instruments for medical purposes, namely, for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; diagnostic testing kits containing diagnostic testing apparatus for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; point of care medical devices for use in analyzing and assessing the presence of active bacterial infections and analyzing and assessing Antimicrobial Resistance (AMR) status; screening kits consisting of medical screening and testing apparatus for the diagnosis of disease, detection and/or identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolic expression, inflammation, and immune suppression and/or immune disorders for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and/or analysis of epigenetic alterations, analysis of response to therapy; all of the foregoing excluding heart pacemakers and stethoscopes and orthopedic implants and excluding apparatus, instruments and devices for use with orthopedic surgery and excluding surgical staplers and accessories therefor
Class 042
Scientific and technological services and research and design relating thereto, in the field of DNA analysis services for scientific research analysis, and scientific research consulting in the field of genetics; scientific genetic research; genetic engineering services for scientific purposes; scientific research in the field of genetics and genetic engineering; scientific research relating to genetics; chemistry services, namely, chemistry research services; research relating to chemistry; scientific research relating to chemistry; research in the field of chemistry; laboratory analysis in the field of chemistry; development of medical diagnostic apparatus; design of medical diagnostic apparatus; research relating to molecular sciences; analysis of data generated by scientific and medical experiments and tests; biological, bacteriological, chemical, biochemical, DNA, RNA, protein, polynucleic acid and molecular analysis and evaluation services for scientific purposes and medical research purposes; DNA and RNA and polynucleic acid and protein sequencing, analysis and evaluation services, for scientific purposes and medical research purposes; genome sequencing services and the analysis and evaluation of data resulting therefrom, for scientific purposes and medical research purposes; scientific analysis and the provision of reports in conjunction therewith relating to scientific and medical experiments, relating to the results of scientific and medical experiments and tests, relating to the analysis and evaluation of scientific and medical data, and relating to data generated by scientific and medical experiments and tests; scientific and medical research and development services in the field of medical research and genetics; custom design and development of biochemical assays

Additional Information

Design Mark
The mark consists of the word "INSIGNIA" in stylized form.

Classification

International Classes
001 005 010 042